Committee opinion no. 620: Salpingectomy for ovarian cancer prevention.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 25560145.
- Also identified by DOI 10.1097/01.AOG.0000459871.88564.09.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Ovarian cancer has the highest mortality rate out of all types of gynecologic cancer and is the fifth leading cause of cancer deaths among women. Current attempts at screening for ovarian cancer have been unsuccessful and are associated with false-positive test results that lead to unnecessary surgery and surgical complications. Prophylactic salpingectomy may offer clinicians the opportunity to prevent ovarian cancer in their patients. Randomized controlled trials are needed to support the validity of this approach to reduce the incidence of ovarian cancer. The approach to hysterectomy or sterilization should not be influenced by the theoretical benefit of salpingectomy. Surgeons should continue to observe and practice minimally invasive techniques.
Medical subject headings
- Ovarian Neoplasms
- Salpingectomy